Site icon Impactiviti

Impactiviti Daily 050410 Top Pharma News

I had an absolutely delightful time at the SOBCon conference this past weekend, interacting with a great group of very high-quality entrepreneurs/social media types. Summary blog post here.


FDA to Sepracor on new anti-epileptic drug candidate (STEDESA) – Nah.

FDA to AstraZeneca/Pozen on arthritis drug (VIMOVO) – cleared for takeoff.

Obamacare and the drug stock sell-off.


Initial Sales Training/Product Training – Getting new pharma/biotech sales reps up to speed is a major challenge.  Impactiviti’s partner network has the experienced, high-quality training providers you need.  Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for recommendations.


For a contrarian industry view – Marcia Angell on Big Pharma, Bad Medicine

Today’s sunrise, from my backyard in Boonton, NJ. Stunning.


Fire-breathing manholes in Manhattan. I just like the fireman’s quote…!


Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)

Visit the Impactiviti Job Board

Sign up for the Impactiviti Connection twice-monthly e-newsletter (see sample)


Exit mobile version